AzTrials
AzTrials

Frailty(ProPEL)NCT04293653

Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy

A study testing Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy in people with Frailty and Surgery--Complications, run by Haukeland University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the ProPEL study the effect of a protocol designed for elderly patients about to undergo emergency abdominal surgery will be investigated. The protocol addresses issues of both frailty and ceiling-of -care decisions. Read more about this study

Who is it for?
Ages 75 years and olderHealthy volunteers can take part
Conditions the study is for
Frailty, Surgery--Complications, Outcome, Fatal
What is being tested?
Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
156 participants
Where
1 siteNorway
Study dates
21 Jan 2020to 2 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Patients above 75 years with clinical suspicion of abdominal condition requiring surgery

Who cannot join

  • Former inclusion in "ProPEL"
  • Surgery for incarcerated hernia without laparotomy
  • Appendectomy without laparotomy
  • Palliative surgery for already known inoperable gastrointestinal tumor
  • Palliation without surgical treatment
  • Vascular surgery

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Haukeland University Hospital

    Bergen, 5021

Other trials in Norway

About this study

In the ProPEL study the effect of a protocol designed for elderly patients about to undergo emergency abdominal surgery will be investigated. The protocol addresses issues of both frailty and ceiling-of -care decisions.

Read the detailed description

In the "ProPEL" study, investigators will test the effect of a care bundle designed for patients aged ≥75 years undergoing emergency laparotomy/laparoscopy. An interdisciplinary team of anesthetists, intensivists, surgeons, and geriatricians developed the care bundle, and the essential elements are frailty scoring, surveillance and optimization of patients, surgical treatment within predefined criteria, and postoperative delirium monitoring.

Preoperatively, patients with abdominal pathology requiring emergency surgery will be evaluated for frailty by the surgical team, using standardized frailty scores. Palliative care could be an alternative to surgery in very frail patients. The decision to not perform surgery is a clinical decision made with the patient and/or relatives in a shared decision-making process. Frailty scoring can assist in this procedure.

The effect of the care-bundle will be compared to a historical cohort, using 30-day mortality as the primary outcome.

Being tested
Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy
Medical subject headings
Frailty, Postoperative Complications, Digestive System Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protocol for patients above 75 undergoing emergency laparotomy or laparoscopyOther

    See above section

Study groups in NCT04293653
Study groupRoleWhat they receive
Care bundleExperimentalPatients above 75 years where emergency surgery is indicated, deemed fit for surgery, will be included in a perioperative care-bundle. While waiting for surgery, patients will be monitored and optimized if their condition deteriorates. Antibiotics will be administered if indicated. Surgery will be delivered within 2h to 72h, depending on the suspected abdominal pathology and the patient's clinical condition.
Receives: Other: Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Composite score of 30-day mortality and postoperative complications

    Composite score will be calculated using the Comprehensive Complication Index ranging from 0 points (uneventful postoperative recovery) to 100 points (postoperative death). One investigator will review the patient's medical record postoperatively to investigate if any medical complication has occurred. Complications are defined according to the EPCO definitions and graded according to the Clavien-Dindo classification system.

    Measured: Up to 30 days after the performance of emergency abdominal surgery

Secondary outcomes (11)
  1. Postoperative complications

    Number of patients having a postoperative complication as defined by the European Perioperative Clinical Outcome Definitions (EPCO) will be reported. The EPCO definitions state universal description of various common postoperative complications, like f.ex pulmonary complications, major adverse cardiac events, urinary tract infections and so on. Thus, postoperative complications are reported in a uniform way.

    We will grade complications according to the Clavien-Dindo classification. According to this classification postoperative complications are graded from 1 to 5, where 1 indicates least severity of complication and 5 indicating worst severity. We will report number of patients having complications from grade 2 to grade 5.

    Measured: up to 90 days after date of emergency surgery

  2. Frequency of post-operative delirium

    Number of patients having postoperative delirium as defined by the screening tool 4 AT. On this 4-item screening tool for delirium patients are scored from 0 (minimum) up to 12 points (maximum). Screening for delirium is positive if score is 4 or above.

    Measured: up to 30 days after emergency surgery

  3. Length of stay in hospital after EAS

    Number of days spent in hospital after EAS

    Measured: up to 90 days after emergency surgery

  4. Patients' Level of independency as measured by the Barthel Activity of Daily Living Index before surgery and one year after surgery

    Activity of Daily Living (ADL) is measured using the Barthel ADL-index (Norwegian Version), a validated 10-item questionnaire. In this scale the patients level of functioning is described and assigned from 0 to 20 points. Zero points indicate total dependency and 20 points indicate Complete independency in Activities of Daily Living.

    Measured: Patients will be assessed with the BArthel ADL-index when admitted to hospital and again one year after emergency abdominal surgery.

  5. Level of care at discharge from hospital and one year after EAS

    Number of patients discharged to own home after EAS. Number of patients discharged to nursing home after EAS. Number of patients living in own home or in nursing home one year after EAS.

    Measured: 1 year after EAS.

  6. 1-year mortality

    Number of deaths within 1 year after emergency abdominal surgery (EAS)

    Measured: From time of EAS performed and up to 1 year

  7. Days at home in first postoperative year

    Number of days living in own home first year after EAS

    Measured: From date of discharge from hospital after EAS and up to one year postoperatively

  8. Readmissions after EAS

    Number of patients readmitted to hospital after first being discharged from hospital after EAS

    Measured: From 8 hours after primary discharge from hospital after EAS until 30 days after primary discharge.

  9. Patient Reported Outcome Measures (PROM)one year after EAS

    Patients report on own Health performance as measured by the 36-Item Short Form Survey. In this survey patients subjective health status is described using 36 standardized questions. Patients will also be asked about their willingness to undergo same procedure again, if indicated.

    Measured: One year after procedure performed (EAS).

  10. 5-year survival

    Number of Deaths occurring within 5 years after EAS

    Measured: From inclusion in study and up to five years after EAS.

  11. 30-day mortality in all patients with indication to undergo surgery

    30-day mortality rate in palliative and operated patients

    Measured: Time (days) up to 30 days after treatment decision (palliation or surgery) is made

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2020
  2. Study start21 Jan 2020
  3. Primary completion30 Jun 2021
  4. Study completion2 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
A care-bundle developed for patients above 75 years undergoing emergency abdominal surgery will be investigated, and the results will be compared to a group of historical controls operated at Haukeland University Hospital in 2016-2017, using 30-day mortality as the primary outcome.
Masking
None (open label)
Enrolment
156 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04293653
Sponsor's protocol ID
REK7110
Acronym
(ProPEL)
Status last verified
Aug 2023
First submitted
2 Jan 2020
Last updated
4 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy in people with Frailty and Surgery--Complications, run by Haukeland University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Composite score of 30-day mortality and postoperative complications (time frame: Up to 30 days after the performance of emergency abdominal surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
(ProPEL) Clinical Trial NCT04293653 | AzTrials